Tissue factor pathway inhibitor

From Wikipedia, the free encyclopedia


Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
PDB rendering based on 1adz.
Available structures: 1adz, 1irh, 1tfx
Identifiers
Symbol(s) TFPI; TFI; EPI; LACI
External IDs OMIM: 152310 MGI: 1095418 HomoloGene: 4579
RNA expression pattern

More reference expression data
Orthologs
Human Mouse
Entrez 7035 21788
Ensembl ENSG00000003436 ENSMUSG00000027082
Uniprot P10646 O54819
Refseq NM_001032281 (mRNA)
NP_001027452 (protein)		 NM_011576 (mRNA)
NP_035706 (protein)
Location Chr 2: 188.04 - 188.13 Mb Chr 2: 84.23 - 84.28 Mb
Pubmed search [1] [2]

Tissue factor pathway inhibitor (or TFPI) is a single-chain polypeptide which can reversibly inhibit Factor Xa (Xa). While Xa is inhibited, the Xa-TFPI complex can subsequently also inhibit the FVIIa-TF complex. TFPI contributes significantly to the inhibition of Xa in vivo, despite being present at concentrations of only 2.5nM.

Contents

[edit] Genetics

The gene for TFPI is located on chromosome 2q31-q32.1, and has nine exons which span 70kb. The gene has not been completely sequenced yet. A similar gene, termed TFPI2, has been identified on chromosome 7q22; in addition to TFPI activity, its product also has retinal pigment epithelial cell growth-promoting properties.

[edit] Protein structure

TFPI has a relative molecular mass of 34000 to 40000 depending on the degree of proteolysis of the C-terminal region.

[edit] See also

[edit] External links

[edit] References

[edit] Further reading

  • Broze GJ, Girard TJ, Novotny WF (1991). "Regulation of coagulation by a multivalent Kunitz-type inhibitor.". Biochemistry 29 (33): 7539–46. PMID 2271516. 
  • McVey JH (2000). "Tissue factor pathway.". Baillieres Best Pract. Res. Clin. Haematol. 12 (3): 361–72. PMID 10856975. 
  • Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP (2002). "Structure and biology of tissue factor pathway inhibitor.". Thromb. Haemost. 86 (4): 959–72. PMID 11686353. 
  • Witt I (2002). "[Tissue factor pathway inhibitor: biochemistry, molecular biology, physiology and physiopathology]". Hamostaseologie 22 (2): 30–5. doi:10.1267/Hamo02020071. PMID 12193974. 
  • Lwaleed BA, Bass PS (2006). "Tissue factor pathway inhibitor: structure, biology and involvement in disease.". J. Pathol. 208 (3): 327–39. doi:10.1002/path.1871. PMID 16261634. 
  • Van der Logt CP, Kluck PM, Wiegant J, et al. (1992). "Refined regional assignment of the human tissue factor pathway inhibitor (TFPI) gene to chromosome band 2q32 by non-isotopic in situ hybridization.". Hum. Genet. 89 (5): 577–8. PMID 1353057. 
  • Higuchi DA, Wun TC, Likert KM, Broze GJ (1992). "The effect of leukocyte elastase on tissue factor pathway inhibitor.". Blood 79 (7): 1712–9. PMID 1558967. 
  • van der Logt CP, Reitsma PH, Bertina RM (1991). "Intron-exon organization of the human gene coding for the lipoprotein-associated coagulation inhibitor: the factor Xa dependent inhibitor of the extrinsic pathway of coagulation.". Biochemistry 30 (6): 1571–7. PMID 1993173. 
  • Girard TJ, Eddy R, Wesselschmidt RL, et al. (1991). "Structure of the human lipoprotein-associated coagulation inhibitor gene. Intro/exon gene organization and localization of the gene to chromosome 2.". J. Biol. Chem. 266 (8): 5036–41. PMID 2002045. 
  • Wun TC, Kretzmer KK, Girard TJ, et al. (1988). "Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.". J. Biol. Chem. 263 (13): 6001–4. PMID 2452157. 
  • Novotny WF, Girard TJ, Miletich JP, Broze GJ (1989). "Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.". J. Biol. Chem. 264 (31): 18832–7. PMID 2553722. 
  • Girard TJ, Warren LA, Novotny WF, et al. (1989). "Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein.". Thromb. Res. 55 (1): 37–50. PMID 2781520. 
  • Girard TJ, Warren LA, Novotny WF, et al. (1989). "Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor.". Nature 338 (6215): 518–20. doi:10.1038/338518a0. PMID 2927510. 
  • Broze GJ, Miletich JP (1987). "Characterization of the inhibition of tissue factor in serum.". Blood 69 (1): 150–5. PMID 3024756. 
  • Broze GJ, Warren LA, Novotny WF, et al. (1988). "The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.". Blood 71 (2): 335–43. PMID 3422166. 
  • Rao LV, Rapaport SI (1987). "Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation.". Blood 69 (2): 645–51. PMID 3492226. 
  • Stubbs MT, Huber R, Bode W (1996). "Crystal structures of factor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of factor Xa and selectivity against thrombin.". FEBS Lett. 375 (1-2): 103–7. PMID 7498454. 
  • Warshawsky I, Bu G, Mast A, et al. (1995). "The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo.". J. Clin. Invest. 95 (4): 1773–81. PMID 7706485. 
  • Broze GJ, Lange GW, Duffin KL, MacPhail L (1995). "Heterogeneity of plasma tissue factor pathway inhibitor.". Blood Coagul. Fibrinolysis 5 (4): 551–9. PMID 7841311. 
v • d • e
Proteins: coagulation
Coagulation factors
primary hemostasis: vWF

intrinsic pathway: HMWK/Bradykinin - Kallikrein - Hageman / FXII - FXI - FIX - FVIII

extrinsic pathway: Tissue factor / FIII - FVII

common pathway: FX - FV - (Pro)thrombin / FII, Fibrin / FI - FXIII
Inhibitors
Fibrinolysis
This medical article is a stub. You can help Wikipedia by expanding it.